Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics

References

• Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–1500. doi:10.1161/CIRCRESAHA.120.316101
   PubMed Web of Science ®Google Scholar
• Mayoral LP, Andrade GM, Mayoral EP, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151(1):11–21. doi:10.4103/ijmr.IJMR_1768_17
   PubMed Web of Science ®Google Scholar
• Pan X, Yue L, Ban J, Ren L, Chen S. Effects of semaglutide on cardiac protein expression and cardiac function of obese mice. J Inflamm Res. 2022;15:6409–6425. doi:10.2147/JIR.S391859
   PubMed Web of Science ®Google Scholar
• Ying W, Fu W, Lee YS, Olefsky JM. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81–90. doi:10.1038/s41574-019-0286-3
   PubMed Web of Science ®Google Scholar
• Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci. 2019;20(10):2519. doi:10.3390/ijms20102519
   PubMed Web of Science ®Google Scholar
• Pan X, Chen S, Chen X, et al. Effect of high-fat diet and empagliflozin on cardiac proteins in mice. Nutr Metab. 2022;19(1):69. doi:10.1186/s12986-022-00705-0
   Google Scholar
• Rosengren A. Obesity and cardiovascular health: the size of the problem. Eur Heart J. 2021;42(34):3404–3406. doi:10.1093/eurheartj/ehab518
   PubMed Web of Science ®Google Scholar
• Mouton AJ, Li X, Hall ME, Hall JE. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. 2020;126(6):789–806. doi:10.1161/CIRCRESAHA.119.312321
   PubMed Web of Science ®Google Scholar
• Abeyratne T, Perera R, Fernando S. Obesity and cardiovascular risk among Sri Lankan adolescents: association of adipokines with anthropometric indices of obesity and lipid profile. Nutrition. 2020;78:110942. doi:10.1016/j.nut.2020.110942
   PubMed Web of Science ®Google Scholar
• Ionică LN, Gaiță L, Bînă AM, et al. Metformin alleviates monoamine oxidase-related vascular oxidative stress and endothelial dysfunction in rats with diet-induced obesity. Mol Cell Biochem. 2021;476(11):4019–4029. doi:10.1007/s11010-021-04194-2
   PubMed Web of Science ®Google Scholar
• Zhao S, Kusminski CM, Scherer PE. Adiponectin, leptin and cardiovascular disorders. Circ Res. 2021;128(1):136–149. doi:10.1161/CIRCRESAHA.120.314458
   PubMed Web of Science ®Google Scholar
• Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951–968. doi:10.1161/CIRCRESAHA.121.318093
   PubMed Web of Science ®Google Scholar
• Zeng Q, Dong SY, Wang ML, Li JM, Ren CL, Gao CQ. Obesity and novel cardiovascular markers in a population without diabetes and cardiovascular disease in China. Prev Med. 2016;91:62–69. doi:10.1016/j.ypmed.2016.08.001
   PubMed Web of Science ®Google Scholar
• Hulsmans M, Holvoet P. MicroRNAs as early biomarkers in obesity and related metabolic and cardiovascular diseases. Curr Pharm Des. 2013;19(32):5704–5717. doi:10.2174/13816128113199990364
   PubMed Web of Science ®Google Scholar
• Vileigas DF, Harman VM, Freire PP, et al. Landscape of heart proteome changes in a diet-induced obesity model. Sci Rep. 2019;9(1):18050. doi:10.1038/s41598-019-54522-2
   PubMed Web of Science ®Google Scholar
• Liśkiewicz AD, Marczak Ł, Bogus K, Liśkiewicz D, Przybyła M, Lewin-Kowalik J. Proteomic and structural manifestations of cardiomyopathy in rat models of obesity and weight loss. Front Endocrinol. 2021;12:568197. doi:10.3389/fendo.2021.568197
   PubMed Web of Science ®Google Scholar
• Biobaku F, Ghanim H, Batra M, Dandona P. Macronutrient-mediated inflammation and oxidative stress: relevance to insulin resistance, obesity, and atherogenesis. J Clin Endocrinol Metab. 2019;104(12):6118–6128. doi:10.1210/jc.2018-01833
   PubMed Web of Science ®Google Scholar
• Lefranc C, Friederich-Persson M, Palacios-Ramirez R, Nguyen Dinh Cat A. Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor. J Endocrinol. 2018;238(3):R143–R159. doi:10.1530/JOE-18-0163
   PubMed Web of Science ®Google Scholar
• Cafe SL, Nixon B, Dun MD, Roman SD, Bernstein IR, Bromfield EG. Oxidative stress dysregulates protein homeostasis within the male germ line. Antioxid Redox Signal. 2020;32(8):487–503. doi:10.1089/ars.2019.7832
   PubMed Web of Science ®Google Scholar
• Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183–193. doi:10.1016/j.lfs.2016.02.002
   PubMed Web of Science ®Google Scholar
• Holvoet P, Kritchevsky SB, Tracy RP, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes. 2004;53(4):1068–1073. doi:10.2337/diabetes.53.4.1068
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911–920. doi:10.1016/j.jaci.2005.02.023
   PubMed Web of Science ®Google Scholar
• Sakhaei F, Keshvari M, Asgary S, Salehizadeh L, Rastqar A, Samsam-Shariat SZ. Enzymatic antioxidant system and endothelial function in patients with metabolic syndrome. ARYA Atheroscler. 2020;16(2):94–101. doi:10.22122/arya.v16i2.1813
   PubMed Web of Science ®Google Scholar
• Liu B, Yi W, Mao X, Yang L, Rao C. Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis. Am J Physiol Endocrinol Metab. 2021;320(5):E925–E937. doi:10.1152/ajpendo.00614.2020
   PubMed Web of Science ®Google Scholar
• Zhang J, Sun M, Li R, et al. Ech1 is a potent suppressor of lymphatic metastasis in hepatocarcinoma. Biomed Pharmacother. 2013;67(7):557–560. doi:10.1016/j.biopha.2013.03.018
   PubMed Web of Science ®Google Scholar
• Huang D, Liu B, Huang K, Huang K. Enoyl coenzyme A hydratase 1 protects against high-fat-diet-induced hepatic steatosis and insulin resistance. Biochem Biophys Res Commun. 2018;499(3):403–409. doi:10.1016/j.bbrc.2018.03.052
   PubMed Web of Science ®Google Scholar
• Mao X, Huang D, Rao C, et al. Enoyl coenzyme A hydratase 1 combats obesity and related metabolic disorders by promoting adipose tissue browning. Am J Physiol Endocrinol Metab. 2020;318(3):E318–E329. doi:10.1152/ajpendo.00424.2019
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang J, Yan Z, et al. DECR1 directly activates HSL to promote lipolysis in cervical cancer cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867(3):159090. doi:10.1016/j.bbalip.2021.159090
   PubMed Web of Science ®Google Scholar
• Nassar ZD, Mah CY, Dehairs J, et al. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife. 2020;9:e54166. doi:10.7554/eLife.54166
   PubMed Web of Science ®Google Scholar
• Ursini-Siegel J, Rajput AB, Lu H, et al. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development. Mol Cell Biol. 2007;27(18):6361–6371. doi:10.1128/MCB.00686-07
   PubMed Web of Science ®Google Scholar
• Wei XH, Guo X, Pan CS, et al. Quantitative proteomics reveal that metabolic improvement contributes to the cardioprotective effect of T89 on isoproterenol-induced cardiac injury. Front Physiol. 2021;12:653349. doi:10.3389/fphys.2021.653349
   PubMed Web of Science ®Google Scholar
• Lee SA, Lee J, Kim K, et al. The peroxisomal localization of Hsd17b4 is regulated by its interaction with phosphatidylserine. Mol Cells. 2021;44(4):214–222. doi:10.14348/molcells.2021.2217
   PubMed Web of Science ®Google Scholar
• Han A, Xu R, Liu Y, Yin X, Lin Z, Yang W. HSDL2 acts as a promoter in pancreatic cancer by regulating cell proliferation and lipid metabolism. Onco Targets Ther. 2021;14:435–444. doi:10.2147/OTT.S287722
   PubMed Web of Science ®Google Scholar
• Huang H, Liu R, Huang Y, et al. Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer. Aging. 2020;12(14):14699–14717. doi:10.18632/aging.103530
   PubMedGoogle Scholar
• Shi Y, Mao Z, Huang Y, et al. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression. Biosci Rep. 2020;40(4):BSR20200348. doi:10.1042/BSR20200348
   PubMedGoogle Scholar
• Li X, Ma R, Liu Y, et al. One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency. Clin Chim Acta. 2020;503:218–222. doi:10.1016/j.cca.2019.11.034
   PubMed Web of Science ®Google Scholar
• Tucci S, Flögel U, Hermann S, Sturm M, Schäfers M, Spiekerkoetter U. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice. Biochim Biophys Acta. 2014;1842(5):677–685. doi:10.1016/j.bbadis.2014.02.001
   PubMed Web of Science ®Google Scholar
• Teng P, Xu X, Ni C, et al. Identification of key genes in calcific aortic valve disease by integrated bioinformatics analysis. Medicine. 2020;99(29):e21286. doi:10.1097/MD.0000000000021286
   PubMed Web of Science ®Google Scholar
• Knottnerus SJG, Mengarelli I, Wüst RCI, et al. Electrophysiological abnormalities in VLCAD deficient hiPSC-cardiomyocytes can be improved by lowering accumulation of fatty acid oxidation intermediates. Int J Mol Sci. 2020;21(7):2589. doi:10.3390/ijms21072589
   PubMed Web of Science ®Google Scholar
• Ohn JH, Hwang JY, Moon MK, et al. Small heterodimer partner (SHP) deficiency protects myocardia from lipid accumulation in high fat diet-fed mice. PLoS One. 2017;12(10):e0186021. doi:10.1371/journal.pone.0186021
   PubMed Web of Science ®Google Scholar